However, interest in therapeutics based on nucleic acids has increased rapidly, driven partly by the astounding success of mRNA based vaccines for COVID-19 and new gene therapy approaches. Nucleic ...

Primrose Bio’s advanced technology for manufacturing nucleic acids and proteins makes it the partner of choice for pharma companies developing new vaccines, therapeutics and bio-based products.

vaccines and next-generation biologic therapeutics. Primrose’s unique and broad capabilities in nucleic acid engineering, molecular evolution and protein expression allow the company to create ...